Publications (53) Publications de MICHAL LETEK POLBERG

2024

  1. Aprendizaje-Servicio en el entorno rural de León

    Innovación docente en la Universidad de León (Servicio de Publicaciones), pp. 165-172

  2. Innovative Strategies in Drug Repurposing to Tackle Intracellular Bacterial Pathogens

    Antibiotics, Vol. 13, Núm. 9

2023

  1. Editorial: Novel approaches to prevent and treat intracellular bacterial infections

    Frontiers in Microbiology

2022

  1. Understanding microRNAs in the Context of Infection to Find New Treatments against Human Bacterial Pathogens

    Antibiotics, Vol. 11, Núm. 3

2021

  1. Drug Repurposing: A Quick and Easy Way of Finding New Medicines

    Frontiers for Young Minds, Vol. 8

  2. Novel Methods to Identify Oxidative Stress-Producing Antibiotics

    Methods in Molecular Biology (Humana Press Inc.), pp. 249-261

  3. Novel treatments and preventative strategies against food-poisoning caused by staphylococcal species

    Pathogens, Vol. 10, Núm. 2, pp. 1-12

2020

  1. A novel screening strategy reveals ROS-Generating antimicrobials that act synergistically against the intracellular veterinary pathogen Rhodococcus equi

    Antioxidants, Vol. 9, Núm. 2

  2. Alexander Fleming, The Discoverer of the Antibiotic Effects of Penicillin

    Frontiers for Young Minds, Vol. 7

  3. Alternative anti-infective treatments to traditional antibiotherapy against staphylococcal veterinary pathogens

    Antibiotics, Vol. 9, Núm. 10, pp. 1-13

  4. Comparative evaluation of the antimicrobial and mucus induction properties of selected bacillus strains against enterotoxigenic escherichia coli

    Antibiotics, Vol. 9, Núm. 12, pp. 1-10

  5. Estudio de la importancia de los mecanismos Redox en patógenos intracelulares

    SEM@foro, Núm. 70, pp. 42-43

  6. Novel treatments against mycobacterium tuberculosis based on drug repurposing

    Antibiotics, Vol. 9, Núm. 9, pp. 1-12

  7. Oxidative stress-generating antimicrobials, a novel strategy to overcome antibacterial resistance

    Antioxidants, Vol. 9, Núm. 5

  8. The extracellular thioredoxin Etrx3 is required for macrophage infection in Rhodococcus equi

    Veterinary Research, Vol. 51, Núm. 1

2019

  1. Acetaminophen cytotoxicity in HepG2 cells is associated with a decoupling of glycolysis from the TCA cycle, loss of NADPH production, and suppression of anabolism

    Archives of Toxicology, Vol. 93, Núm. 2, pp. 341-353

  2. Host-directed kinase inhibitors act as novel therapies against intracellular Staphylococcus aureus

    Scientific Reports, Vol. 9, Núm. 1

  3. Host-targeted therapeutics against multidrug resistant intracellular Staphylococcus aureus

    Antibiotics, Vol. 8, Núm. 4

  4. Identification of novel targets for host-directed therapeutics against intracellular Staphylococcus aureus

    Scientific Reports, Vol. 9, Núm. 1

  5. Intracellular staphylococcus aureus elicits the production of host very long-chain saturated fatty acids with antimicrobial activity

    Metabolites, Vol. 9, Núm. 7